Evaluating FEB technology for disease diagnostic systems.

Using FEB technology to develop point-of-care applications for genetic diseases.

Evaluating FEB technology to use in hand-held drug detection devices.

Utilizing Agile R100 to gather in vitro kinetic binding data for peer-reviewed publications, including Nature.

Evaluating the diagnostic capabilities of FEB technology.

A co-developer of graphene applications.

Co-developer of the only commercial graphene biosensor fabrication process in the world.

Packager of large-scale quantities of graphene biosensor chips.

Multi-disciplinary engineering firm creating the electronics, mechanics, and software for Agile products.

Co-developing graphene product fabrication.

Nanomedical Diagnostics is a supporter of the Competency X program at Del Lago Academy, a local San Diego high school.

Nanomedical Diagnostics was one of nine companies accepted out of 104 applicants for this top San Diego start-up incubator.